argenx SE reported $340.62M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
AstraZeneca USD 6.47B 583M Jun/2025
Galapagos EUR 38.52M 12.67M Mar/2025
Genmab DKK 13M 1000K Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 986M 50M Dec/2024
Qiagen NV USD 292.55M 11.19M Jun/2025
UCB 1.31B 173M Dec/2024